Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic Therapies to Mitigate Radiation-Associated Heart Disease
NCT07685938Phase 2Recruiting
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Aug 2026
- Primary completion
- Feb 2029
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin, lisinopril in radiation-induced heart disease (RIHD), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Aug 2026; status: recruiting.
02
Drugs
atorvastatinlisinopril
03
Conditions
radiation-induced heart disease (RIHD)
Beyond the preview
Go deeper on NCT07685938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07685938.